Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04054141 · ClinicalTrials.gov registry record · NA

rTMS in Treatment of Spasticity

A NA study, sponsored by Hospital for Special Surgery, New York.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT04054141 is a NA study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04054141, a NA study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

This is an open-label clinical trial to determine the safety and efficacy of rTMS in reducing spasticity and improving quality of life among patients with upper motor neuron predominant motor neuron disease (MND).

Interventions

  • DEVICE Mag Stim

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2018-09-01
Est. Completion 2022-08-16
Phase NA

What the Registry Record Tells You About NCT04054141

The ClinicalTrials.gov registry entry for NCT04054141 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mag Stim is the first listed.

NCT04054141 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04054141 about?

NCT04054141 is a clinical study titled "rTMS in Treatment of Spasticity". This is an open-label clinical trial to determine the safety and efficacy of rTMS in reducing spasticity and improving quality of life among patients with upper motor neuron predominant motor neuron disease (MND).

What is the current status of trial NCT04054141?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-09-01. Estimated completion is 2022-08-16.

What interventions are being tested in trial NCT04054141?

The interventions under investigation include: Mag Stim (DEVICE).

Who is sponsoring clinical trial NCT04054141?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.